Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Soleno Therapeutics, Inc. (SLNO) had Debt to Capital Ratio of 0.18 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-43.77M |
|
-- |
|
-- |
|
$45.74M |
|
$-45.74M |
|
$1.97M |
|
$-43.77M |
|
$-43.77M |
|
$-43.77M |
|
$-43.77M |
|
$-43.77M |
|
$-43.77M |
|
$-45.74M |
|
$-45.24M |
|
46.18M |
|
46.18M |
|
$-0.95 |
|
$-0.95 |
|
| Balance Sheet Financials | |
$308.92M |
|
$0.17M |
|
$9.18M |
|
$318.09M |
|
$15.73M |
|
$49.84M |
|
$70.10M |
|
$85.83M |
|
$232.26M |
|
$225.94M |
|
$232.26M |
|
48.53M |
|
| Cash Flow Statement Financials | |
$-32.75M |
|
$22.94M |
|
$3.22M |
|
$87.93M |
|
$81.33M |
|
$-6.60M |
|
$14.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.64 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.18 |
0.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-32.76M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.85% |
|
-19.37% |
|
-13.76% |
|
-15.52% |
|
$4.79 |
|
$-0.71 |
|
$-0.71 |
|